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Abstract 24
Both lymphatic and distant metastases arise through cancer cell migration and 25 colonization of ectopic sites. Nonetheless, the two metastasis types are associated with 26 significantly different clinical outcomes, suggesting that distinct biological mechanisms 27 may drive their formation. Here we show fundamental differences in the seeding patterns 28 of lymphatic and distant metastases. Analyzing the reconstructed phylogenies of human 29 colorectal cancers, we find that distant metastases typically are monophyletic, originating 30 from one common ancestor. Lymphatic metastases, in contrast, are almost exclusively 31 polyphyletic and can be seeded from many primary tumor regions. We develop a rigorous 32 mathematical framework for quantifying the phylogenetic diversity of metastases while 33 accounting for differential lesion sampling among patients. Our results indicate that a 34 smaller fraction of primary tumor cells gives rise to distant metastases than lymphatic 35 metastases. Thus, the two metastasis types exhibit profoundly distinct phylogenetic traits, 36
indicating that different evolutionary mechanisms may drive their formation and influence 37 their clinical behavior. 38
Main text 39
In most cancers, metastasis to distant organs confers a considerably worse prognosis 40 than spread to locoregional lymph nodes. For example, 5-year survival for colorectal 41 cancers that have metastasized to local lymph nodes or the pericolonic fat (stage III) is 42 53-90% but drops to 12% for patients with spread to distant organs (stage IV) 1 . The 43 survival difference for patients with locoregional and distant disease is similar for other 44 tumor types, such as breast cancer and melanoma 2, 3 . 45
46
The formation of both lymphatic and distant metastases depends on cancer cell migration 47 and colonization of foreign microenvironments 4 . Given that both types of metastasis 48 require similar cellular abilities 5 and indicate the presence of a potentially lethal cell type 49 capable of ectopic growth, it is worth asking why clinical outcomes of stage IV patients 50 differ so markedly from those of stage III patients. 51
52
The simplest explanation is that distant metastases often affect vital organs such as the 53 liver and the lungs and therefore lead to accelerated death. However, locoregional 54 recurrence may be equally dangerous in some cancer types. For example, autopsy 55 studies have shown that local recurrence was the cause of death in approximately 50% 56 of colorectal cancer patients 6 , highlighting the importance of locoregional disease control. 57
Similarly, in pancreatic cancer, local recurrence has been estimated to be responsible for 58 approximately 30% of deaths 7 . 59 Are lymphatic metastases perhaps easier to remove than distant metastases? 5-year 61 survival for colorectal cancer patients with resectable liver metastases is 25-44% 8 , well 62 above average for stage IV disease, suggesting that surgical management of metastases 63 can make a difference. Yet, clinically, resection of affected lymph nodes is not a high 64 priority in colorectal cancer. Nodes are primarily resected for staging and not for 65 therapeutic purposes 9 . Pre-operative imaging of mesenteric lymph nodes is challenging 10 66 and lymph node harvest practices vary by institution 11 . Therefore, affected nodes 67 probably stay behind in a fraction of patients. In rectal cancer, clinical trials have shown 68 that extended lateral pelvic lymph node dissection did not improve survival 12, 13 , echoing 69 similar findings in breast cancer 14 To investigate the evolution of lymphatic and distant metastases, we took advantage of a 89 recently published collection of colorectal cancer phylogenies 16 . From this study, we 90 selected all patients (n=18) with multiple primary tumor regions (range 2-10) and/or lymph 91 node and/or distant metastases (range 2-10). These data formed the basis of our analysis 92 (see Supplementary Table 1 for detailed patient information). Importantly, this cohort was 93 exhaustively sampled, and a majority of resected metastases of sufficient size and purity 94 were included, minimizing sampling bias 16 . Phylogenies were reconstructed based on 95 small insertions and deletions in hypermutable polyguanine tracts, a method that 96 produces rich mutation data and robust trees 17 . We had previously used this patient 97 cohort to ascertain that most liver metastases originate in the primary tumor and do not 98 share a common subclonal origin with lymph node metastases 16 . Here, we analyzed the 99 evolutionary trees from a fundamentally different perspective, asking whether lymphatic 100 and distant metastases as a group consistently display distinct phylogenetic features. 101 102 Evaluating patient trees ( Fig. 1a and Supplementary Figures 1-3 ), we noticed a recurring 103 pattern. Lymph node metastases and primary tumor samples typically diverged, often in 104 alternating succession, from the tree trunk, while distant lesions usually had one common 105 ancestor and tended to form the terminal branch of the tree ( Supplementary Fig. 4 ). Given 106 the consistency of this observation, we sought to formalize it. First, to avoid sampling 107 bias, we reduced the data set to one sample per lymphatic and distant metastasis. That 108 is, in cases where multiple biopsies were taken from the same metastasis, we randomly 109 removed all but one sample, such that each metastasis was represented by only one 110 biopsy in the final data set (see Supplementary Figs. 1-3 for all phylogenies). Then, we 111 determined the fraction of patients in whom all anatomically distinct distant metastases 112 had one common ancestor and grouped together in a monophyletic clade that did not 113 include any primary tumors or lymphatic metastases. We found that in 67% of patients, 114 distant metastases were part of such a clade. In contrast, lymphatic metastases formed 115 a monophyletic group in only 10% of patients ( Fig. 1b , p = 0.036, two-tailed Fisher's exact 116 test). A slightly altered classification approach in which we considered distant and 117 lymphatic metastases a monophyletic group if the clade contained all metastases but no 118 primary tumor samples (allowing for the other metastasis type to be part of the branch) 119 gave similar results, with 20% and 83% of patients having one common ancestor for all 120 lymphatic and distant metastases, respectively (p = 0.035, two-tailed Fisher's exact test, 121 Supplementary Fig. 5 ). Note that the classification into monophyletic and polyphyletic 122 groups is unrelated to our previously described common and distinct origin categories, 123 which reflect whether lymphatic and distant metastases have a common subclonal 124 origin 16 . For example, all phylogenetic trees in Fig. 1a show polyphyletic lymph node 125 metastases and monophyletic distant metastases, although C45 and C66 belong to the 126 distinct origins category, while C36 shows common origin of lymphatic and distant 127 metastases 16 . 128
We further explored the high phylogenetic homogeneity of distant metastases (Fig. 1b ) 129 by calculating, for every patient, the mean phylogenetic distance (number of internal 130 nodes) separating different primary tumor regions and distinct lymphatic and distant 131 metastases. The distances were not significantly different for primary tumor regions and 132 lymphatic metastases (mean distances of 0.50 vs 0.42) but significantly lower for distant 133 metastases (mean distance of 0.24, p=8.4e-3 and p=0.045, two-tailed Mann-Whitney 134 tests), confirming the relative homogeneity of this group (Fig. 1c) . 135 136 We wondered whether differential sampling of lymph node and distant metastases may 137 have affected the results. For example, if ten lymphatic but only two distant metastases 138 are included in a phylogeny, it is far more likely that all distant metastases will have one 139 common ancestor by chance. We did not observe a significant difference between the 140 number of lymphatic and distant metastases in our data set, but the mean and variance 141 were slightly higher in the lymph node metastasis group (mean 3.7 vs 3.0 metastases, 142 p=0.54, Student's t-test, Fig. 1d) . Additionally, the number of primary tumor regions 143 sampled in each case further affects the odds of finding monophyletic metastasis groups 144 by chance alone. To account for the different number of lesions sampled in each patient, 145
we developed a mathematical framework that allowed us to quantify the likelihood of 146 common origin for any given phylogeny. We define m as the number of metastasis 147 samples under investigation (either lymphatic or distant), and k as the number of all other 148 tumor samples in the phylogeny (Supplementary Methods) . We calculate a root diversity 149 score (RDS) defined by the probability that at least l out of m metastases form a common 150 clade in a tree with = + samples (Supplementary Table 2 ). In other words, the root 151 diversity score denotes the probability that a tree with an equally or more extreme 152 clustering of metastases occurs by chance alone. For example, in subject C36 (Fig. 1a) , 153 the root diversity score for distant metastasis is 0.067, as the likelihood that two distant 154 metastases (m=2) will cluster by chance in a phylogeny with n=9 samples is 6.7%. The 155 power to detect non-random clustering of metastases increases with the number of 156 samples n in a phylogeny ( Fig. 2a) . 157
158
We used the root diversity score to quantify the homogeneity of distant metastases in our 159 cohort. We found that after accounting for the number of other samples (k) in the 160 phylogenies, indeed the root diversity score was generally very low ( Fig. 2b) , even for 161 phylogenies where distant metastases did not form a monophyletic clade. To validate the 162 low root diversity of distant metastases in an independent cohort, we searched the 163 literature for colorectal cancer phylogenies with at least two primary tumor samples and 164 multiple anatomically distinct distant lesions. We found one appropriate study comprising 165 five patients with a total of 17 liver metastases 18 . We calculated the root diversity scores 166 for distant metastases for all five patients (trees are shown in Supplementary Fig. 6 ) and 167 found the smallest possible root diversity score in every case (Fig. 2b) , independently 168 confirming our observation that distant metastases tend to be monophyletic. In 8 out of 169 11 patients with multiple distant lesions in the combined two cohorts, the likelihood that 170 metastases would cluster to the observed degree by chance alone was below 10% 171 (Supplementary Table 2 ). Furthermore, combining all root diversity scores, we calculated 172 a combined p-value of 4.5e10 -7 for the entire patient population. This p-value corresponds 173 to the likelihood that distant metastases would cluster to the observed degree by chance. 174 Thus, we find strong evidence for distant metastasis homogeneity both within individual 175 phylogenies and across the whole patient cohort. 176
Returning to our original question, we next applied the root diversity score to lymphatic 178 and distant metastases in a comparative analysis. The results showed highly significant 179 differences in root diversity between the two metastasis types (mean diversity score of 180 0.69 vs 0.090; p=2.6e10 -3 , two-tailed Mann-Whitney test), confirming that lymphatic 181 metastases are far more likely to be polyphyletic than distant metastases (Fig. 2c) , even 182 after accounting for differential sampling in a mathematically rigorous fashion. 183
184
We wondered whether these differences might be due to treatment effects. Treatment did 185 not affect the majority of patients in the combined two cohorts, as 16 out of 23 cases 186 (70%) had synchronous metastasis. In these cases, all primary and metastatic lesions 187 were resected at the same time. Seven patients had metachronous metastasis and 188 received treatment in the time interval between the resection of the primary tumor and 189 associated lymphatic metastases and the resection of distant metastases. Two of these 190 did not have multiple distant metastases (C65, C39) and therefore were not included in 191 Supplementary Fig. 2) , arguing against an effect of the treatment on the inferred 197 phylogeny. Nonetheless, we recalculated the root diversity score after excluding all 198 treated patients (C66, C36, C69, CRC2 and CRC5) from the analysis and found that the 199 results remained highly significant (7.0e10 -3 , Supplementary Fig. 7) . 200
201
In summary, our results indicate that in colorectal cancer, lymphatic and distant 202 metastases are phylogenetically distinct groups. Lymph node metastases are 203 polyphyletic, mirror the heterogeneity of the primary tumor and are furthermore polyclonal, 204 according to a recent report 19 . These observations suggest the absence of strong 205 selection during the formation of lymph node metastases: many cells from the primary 206 tumor appear capable of migrating to and thriving in lymph nodes. Distant metastases, in 207 contrast, typically have one common ancestor and form a monophyletic group (Fig. 2d) . 208
209
Multiple explanations for the high phylogenetic similarity of distant metastases exist. First, 210 metastases may have given rise to each other [20] [21] [22] . Most lesions in our data set were liver 211 metastases and could have formed through intra-hepatic seeding. Standing on its own, 212 we consider this explanation relatively unlikely, as many phylogenetically similar 213 metastases (e.g. C69, C36, CRC3, CRC4) presented in different liver segments, which 214 are independent functional units with separate vascular systems. Furthermore, the two 215 patients in our cohort who had metastases in different organs (C45 and C38) still showed 216 monophyletic origin of these lesions. 217 218 Second, it is possible that distant metastasis represents a specific selective bottleneck 219 and thereby, in contrast to lymphatic metastasis, selects for a particular subpopulation. 220
The ability to enter and exit the blood stream 23 , travel longer distances 24 , or survive in 221 organ-specific microenvironments 25 may represent such a bottleneck. This possibility is 222 further supported by a recent study which showed that distant metastases in different 223 cancer types were more often monophyletic than expected by chance 26 . The existence of 224 an (epi-) genetically defined metastatic clone has been strongly debated over the years 27 . 225 Our results motivate a continued search for the molecular traits of this clone. It will 226 furthermore be important to determine whether metastasis to different organs selects for 227 different lineages 25 Root diversity score. The root diversity score (RDS) denotes the probability that in a 240 cancer phylogeny with n tumor samples at least l out of m metastases samples form a 241 single clade. We generalized Edwards' and Cavalli-Sforza's approach to calculate the 242 number of distinct phylogenies with a given number of samples in which at least l of m 243 metastases samples form a monophyletic group 28, 29 (Supplementary Methods) . To 244 obtain the probability that such a phylogeny would evolve by chance, we divide this 245 number of phylogenies by the total number of phylogenies with n tumor samples (see 246
in Supplementary Methods). All RDS values are provided in 247 Supplementary Table 2 . 16 . Distant metastases arise from a common ancestor in all cases. Liv, liver metastasis; SB, small bowel metastasis. b | All distant metastases formed a monophyletic clade in 67% (4/6) of patients. All lymphatic metastases formed a monophyletic group in 10% (1/10) of patients (p = 0.036, two-tailed Fisher's exact test).
The black bars denote 90% confidence intervals. c | The normalized mean number of internal phylogenetic nodes that separated a pair of distinct distant metastases was significantly lower than the mean for primary tumor samples (0.24 vs 0.5) or lymphatic metastases (0.24 vs 0.42), respectively. No statistically significant difference was observed between the mean distances of primary tumor samples and lymphatic metastases (p=0.11, two-tailed Mann-Whitney test). Center line, median; box limits, upper b | In both cohorts, the root diversity score decreases as the power to observe a low score increases with the number of sampled distant metastases. k ranges between 2 and 8 in both cohorts. c | The root diversity score was significantly lower for distant metastases than lymphatic metastases (0.09 vs 0.65; p=0.0026; two-tailed Mann-Whitney test).
Center line, median; box limits, upper and lower quartiles; points, outliers. Magenta diamonds illustrate the mean in each group. d | Summary schematic showing that lymphatic metastases can be seeded from many primary tumor regions and mirror the heterogeneity of the primary tumor, while distant metastases are typically formed by one clone, either due to selection or intra-organ metastasis.
